Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial.


UNLABELLED Essentials Statins, especially rosuvastatin, may reduce venous thrombosis risk, but the mechanism is unclear. We performed a randomized trial investigating the effect of rosuvastatin on platelet reactivity. Thromboxane-A2 mediated platelet aggregation was measured before and after rosuvastatin therapy. Rosuvastatin did not inhibit thromboxane… (More)
DOI: 10.1111/jth.13343